chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Tremor, Vomiting
Clinical narrative: diarrhea; trembling; very cold; arm is very tender; shivering; nausea; vomiting around 12pm; fever range from 101.5 to 102; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), TREMOR (trembling), FEELING COLD (very cold), TENDERNESS (arm is very tender) and CHILLS (shivering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced DIARRHOEA (diarrhea), TREMOR (trembling), FEELING COLD (very cold), TENDERNESS (arm is very tender), CHILLS (shivering), NAUSEA (nausea), VOMITING (vomiting around 12pm) and PYREXIA (fever range from 101.5 to 102). At the time of the report, DIARRHOEA (diarrhea), TREMOR (trembling), FEELING COLD (very cold), TENDERNESS (arm is very tender), CHILLS (shivering), NAUSEA (nausea), VOMITING (vomiting around 12pm) and PYREXIA (fever range from 101.5 to 102) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided by reporter no treatment information provided by reporter
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Fatigue
Clinical narrative: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: increased (High) Increased BSL.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   This case was linked to MOD-2021-085914 (Patient Link).
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Heart rate increased, Palpitations, Rash erythematous
Clinical narrative: Difficulty breathing; Dizziness; heart beating fast; Heart racing; Legs shaking; Blurred vision; Red rash patches on left hand, right hand and knuckle; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), HEART RATE INCREASED (heart beating fast), PALPITATIONS (Heart racing) and TREMOR (Legs shaking) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, NORGESTIMATE (TRI ESTARYLLA) for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), HEART RATE INCREASED (heart beating fast), PALPITATIONS (Heart racing), TREMOR (Legs shaking), VISION BLURRED (Blurred vision) and RASH ERYTHEMATOUS (Red rash patches on left hand, right hand and knuckle). On 14-Apr-2021, DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), HEART RATE INCREASED (heart beating fast), PALPITATIONS (Heart racing), TREMOR (Legs shaking) and VISION BLURRED (Blurred vision) had resolved. On 21-Apr-2021, RASH ERYTHEMATOUS (Red rash patches on left hand, right hand and knuckle) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vision blurred
Clinical narrative: Difficulty breathing; Dizziness; heart beating fast; Heart racing; Legs shaking; Blurred vision; Red rash patches on left hand, right hand and knuckle; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), HEART RATE INCREASED (heart beating fast), PALPITATIONS (Heart racing) and TREMOR (Legs shaking) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, NORGESTIMATE (TRI ESTARYLLA) for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), HEART RATE INCREASED (heart beating fast), PALPITATIONS (Heart racing), TREMOR (Legs shaking), VISION BLURRED (Blurred vision) and RASH ERYTHEMATOUS (Red rash patches on left hand, right hand and knuckle). On 14-Apr-2021, DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), HEART RATE INCREASED (heart beating fast), PALPITATIONS (Heart racing), TREMOR (Legs shaking) and VISION BLURRED (Blurred vision) had resolved. On 21-Apr-2021, RASH ERYTHEMATOUS (Red rash patches on left hand, right hand and knuckle) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: Painful arm; fatigue set in and I haven't been able to shake it off; the pain came back a little bit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful arm), FATIGUE (fatigue set in and I haven't been able to shake it off) and PAIN (the pain came back a little bit) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Painful arm), FATIGUE (fatigue set in and I haven't been able to shake it off) and PAIN (the pain came back a little bit). At the time of the report, PAIN IN EXTREMITY (Painful arm), FATIGUE (fatigue set in and I haven't been able to shake it off) and PAIN (the pain came back a little bit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Syringe leaked down her arm during injection; Syringe leaked down her arm during injection; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Syringe leaked down her arm during injection) and DEVICE CONNECTION ISSUE (Syringe leaked down her arm during injection) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced UNDERDOSE (Syringe leaked down her arm during injection) and DEVICE CONNECTION ISSUE (Syringe leaked down her arm during injection). At the time of the report, UNDERDOSE (Syringe leaked down her arm during injection) and DEVICE CONNECTION ISSUE (Syringe leaked down her arm during injection) outcome was unknown. Not Provided          No concomitant medications provided. No treatment information provided.   This case was linked to MOD-2021-085895 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Fatigue
Clinical narrative: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Blood glucose: high (High) Increased BSL.         No concomitant medications reported. No treatment information provided.    This case was linked to MOD-2021-085901 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 2nd shot not administered at 42 day mark; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd shot not administered at 42 day mark) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd shot not administered at 42 day mark). At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd shot not administered at 42 day mark) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Insomnia, Muscle spasms, Paraesthesia, Pyrexia
Clinical narrative: Tingling sensation on inner part of the arm; Crampy; Difficulty in sleeping; Fever; Chills over night; Vomited one time; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation on inner part of the arm), MUSCLE SPASMS (Crampy), INSOMNIA (Difficulty in sleeping), PYREXIA (Fever) and CHILLS (Chills over night) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced MUSCLE SPASMS (Crampy), INSOMNIA (Difficulty in sleeping), PYREXIA (Fever), CHILLS (Chills over night) and VOMITING (Vomited one time). On 18-Apr-2021, the patient experienced PARAESTHESIA (Tingling sensation on inner part of the arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Apr-2021, MUSCLE SPASMS (Crampy), INSOMNIA (Difficulty in sleeping), PYREXIA (Fever), CHILLS (Chills over night) and VOMITING (Vomited one time) had resolved. On 27-Apr-2021, PARAESTHESIA (Tingling sensation on inner part of the arm) had resolved.      No concomitant medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: First dose details, vaccination facility details and event outcome changed from unknown to recovered.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Tingling sensation on inner part of the arm; Crampy; Difficulty in sleeping; Fever; Chills over night; Vomited one time; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation on inner part of the arm), MUSCLE SPASMS (Crampy), INSOMNIA (Difficulty in sleeping), PYREXIA (Fever) and CHILLS (Chills over night) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced MUSCLE SPASMS (Crampy), INSOMNIA (Difficulty in sleeping), PYREXIA (Fever), CHILLS (Chills over night) and VOMITING (Vomited one time). On 18-Apr-2021, the patient experienced PARAESTHESIA (Tingling sensation on inner part of the arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Apr-2021, MUSCLE SPASMS (Crampy), INSOMNIA (Difficulty in sleeping), PYREXIA (Fever), CHILLS (Chills over night) and VOMITING (Vomited one time) had resolved. On 27-Apr-2021, PARAESTHESIA (Tingling sensation on inner part of the arm) had resolved.      No concomitant medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: First dose details, vaccination facility details and event outcome changed from unknown to recovered.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis contact, Fatigue, Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: poison sumac; Sore arm at the injection site; Little fatigue; >35 days between doses; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DERMATITIS CONTACT (poison sumac), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days between doses), VACCINATION SITE PAIN (Sore arm at the injection site) and FATIGUE (Little fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 025A21A) for COVID-19 vaccination.     The patient's past medical history included Diabetes (Improvement A1C down to 6.0) since 04-Sep-2019. Concomitant products included METFORMIN HCL from 04-Sep-2019 to an unknown date, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN + HIDROCLOROTIAZIDA), ATORVASTATIN, MELOXICAM and CETIRIZINE for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days between doses). On an unknown date, the patient experienced DERMATITIS CONTACT (poison sumac), VACCINATION SITE PAIN (Sore arm at the injection site) and FATIGUE (Little fatigue). At the time of the report, DERMATITIS CONTACT (poison sumac), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days between doses) and FATIGUE (Little fatigue) outcome was unknown. Not Provided          This case was linked to MOD-2021-085973 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: significant follow up is added On 24-May-2021: Initial Addiitonal-1: VAERS, medical history, conc meds, AE details and outcome
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: diagnosed with shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (diagnosed with shingles) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced HERPES ZOSTER (diagnosed with shingles). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (diagnosed with shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Nasopharyngitis
Clinical narrative: Have Congestion/Have stuffy nose; Have Cough; I think it is common cold; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Have Congestion/Have stuffy nose), COUGH (Have Cough) and NASOPHARYNGITIS (I think it is common cold) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (Have Congestion/Have stuffy nose), COUGH (Have Cough) and NASOPHARYNGITIS (I think it is common cold). At the time of the report, NASAL CONGESTION (Have Congestion/Have stuffy nose), COUGH (Have Cough) and NASOPHARYNGITIS (I think it is common cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant and treatment details reported
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental exposure to product, Myalgia
Clinical narrative: Needle Leaked and the liquid ran down her arm; Sore Right Arm (Vaccinated Arm); This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT (Needle Leaked and the liquid ran down her arm) and MYALGIA (Sore Right Arm (Vaccinated Arm)) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 22-Apr-2021, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT (Needle Leaked and the liquid ran down her arm) and MYALGIA (Sore Right Arm (Vaccinated Arm)). On 22-Apr-2021, ACCIDENTAL EXPOSURE TO PRODUCT (Needle Leaked and the liquid ran down her arm) had resolved. At the time of the report, MYALGIA (Sore Right Arm (Vaccinated Arm)) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: left collar bone lymph node; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (left collar bone lymph node) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced LYMPHADENOPATHY (left collar bone lymph node). At the time of the report, LYMPHADENOPATHY (left collar bone lymph node) outcome was unknown. Not Provided          No concomitant medication was reported.Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on left arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on left arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 045A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced RASH (rash on left arm). At the time of the report, RASH (rash on left arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment information was provided.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding, Stomatitis
Clinical narrative: She is a breastfeeding mother of a 19 month old; Had sores in her mouth and tongue; This spontaneous case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (She is a breastfeeding mother of a 19 month old) and STOMATITIS (Had sores in her mouth and tongue) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and CLONIDINE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (She is a breastfeeding mother of a 19 month old) and STOMATITIS (Had sores in her mouth and tongue). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (She is a breastfeeding mother of a 19 month old) and STOMATITIS (Had sores in her mouth and tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not provided.   This case was linked to MOD-2021-085546 (Parent-Child Link). This case was linked to MOD-2021-085519 (Patient Link).   See case MOD-2021-085546 for details regarding the child case.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and HEADACHE (headache). At the time of the report, PYREXIA (fever) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up received on 26-MAY-2021.
Sex: U
Vaccine: COVID19
Symptoms: Light chain analysis, Light chain analysis increased
Clinical narrative: Light chain increased; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIGHT CHAIN ANALYSIS INCREASED (Light chain increased) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple myeloma (in remission).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced LIGHT CHAIN ANALYSIS INCREASED (Light chain increased). At the time of the report, LIGHT CHAIN ANALYSIS INCREASED (Light chain increased) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Light chain analysis: increased (High) Increases.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included unspecified multiple immunosuppressants. Treatment information was not provided. Patient received second dose of vaccine in ??-FEB-2021.   This case was linked to MOD-2021-085987 (Patient Link).   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered doses to at least 5 clients 23 hours after vaccine vial was punctured; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered doses to at least 5 clients 23 hours after vaccine vial was punctured) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered doses to at least 5 clients 23 hours after vaccine vial was punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered doses to at least 5 clients 23 hours after vaccine vial was punctured) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported . No treatment medication was reported. She decline to give any information on the 5 patients that have been confirmed to have been administered the vaccine so far
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Nausea, Vomiting
Clinical narrative: Lost appetite; Chills; Fatigue; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Lost appetite), CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea) and VOMITING (Vomiting) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 043B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.".  The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE and POTASSIUM for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced DECREASED APPETITE (Lost appetite), CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, DECREASED APPETITE (Lost appetite), CHILLS (Chills), FATIGUE (Fatigue), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis contact, Fatigue, Vaccination site pain
Clinical narrative: vaccination site pain; Little fatigue; Poison Sumac Rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DERMATITIS CONTACT (Poison Sumac Rash), VACCINATION SITE PAIN (vaccination site pain) and FATIGUE (Little fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Sumac rash (10 or so years age). Concurrent medical conditions included Diabetes (Improvement A1C down to 6.0) since 04-Sep-2019. Concomitant products included METFORMIN HCL from 04-Sep-2019 to an unknown date, ATORVASTATIN, MELOXICAM, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) and CETIRIZINE HYDROCHLORIDE (CETRIZINE) for an unknown indication.    On 01-Mar-2021 at 11:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021 at 8:00 PM, the patient experienced DERMATITIS CONTACT (Poison Sumac Rash). On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain) and FATIGUE (Little fatigue). The patient was treated with PREDNISONE (oral) on 22-Mar-2021 at a dose of 1 dosage form. On 03-Apr-2021, DERMATITIS CONTACT (Poison Sumac Rash) had resolved. At the time of the report, VACCINATION SITE PAIN (vaccination site pain) and FATIGUE (Little fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.       The patient reported that was working in the yard several weeks later trimming hedge. Unknowingly came in contact with poison sumac. The patient experienced rash and blisters resulting in a visit to immediate care facility.   This case was linked to (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow up information received updated patient details, added event (sore arm), concomitant medications, treatment medication(Prednisone). On 24-May-2021: Follow up received updated patient details, medical history, vaccine details, concomitant  medication details, added new event and updated event details. On 02-Jul-2021: Follow-up received updated event outcome.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Fatigue, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (massive hair loss/bare spots), MYALGIA (muscle pains in legs), PYREXIA (fever for 3 or 4 days) and FATIGUE (fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 006B21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced ALOPECIA (massive hair loss/bare spots), MYALGIA (muscle pains in legs), PYREXIA (fever for 3 or 4 days) and FATIGUE (fatigue). The patient was treated with ZINC at an unspecified dose and frequency and BIOTIN at an unspecified dose and frequency. At the time of the report, ALOPECIA (massive hair loss/bare spots), MYALGIA (muscle pains in legs) and FATIGUE (fatigue) outcome was unknown and PYREXIA (fever for 3 or 4 days) had resolved. This case was linked to MOD21-080679 (E2B Linked Report).; Sender's Comments: MOD21-080679:
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: 5x5 inches area hot to the touch; 5-inch by 5-inch reddened, raised; Soreness to arm where had the injection; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE WARMTH (5x5 inches area hot to the touch), INJECTION SITE ERYTHEMA (5-inch by 5-inch reddened, raised) and INJECTION SITE PAIN (Soreness to arm where had the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced INJECTION SITE WARMTH (5x5 inches area hot to the touch), INJECTION SITE ERYTHEMA (5-inch by 5-inch reddened, raised) and INJECTION SITE PAIN (Soreness to arm where had the injection). On 17-Apr-2021, INJECTION SITE WARMTH (5x5 inches area hot to the touch), INJECTION SITE ERYTHEMA (5-inch by 5-inch reddened, raised) and INJECTION SITE PAIN (Soreness to arm where had the injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment medication was not provided.   Reporter did not allow further contact
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: tinnitus got much more intense and distracting - no improvement; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TINNITUS (tinnitus got much more intense and distracting - no improvement) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Tinnitus. Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (tinnitus got much more intense and distracting - no improvement). The patient was treated with FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Tinnitus, at an unspecified dose and frequency. At the time of the report, TINNITUS (tinnitus got much more intense and distracting - no improvement) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included Neti pot
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Goitre, Myalgia
Clinical narrative: Neck swelling; Swollen Neck and thyroid,; soreness in the opposite arm; Rapid HR,; fever; Extreme body ache; Chills,; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Neck swelling), GOITRE (Swollen Neck and thyroid,), PAIN IN EXTREMITY (soreness in the opposite arm), TACHYCARDIA (Rapid HR,) and PYREXIA (fever) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced SWELLING (Neck swelling), GOITRE (Swollen Neck and thyroid,), PAIN IN EXTREMITY (soreness in the opposite arm), TACHYCARDIA (Rapid HR,), PYREXIA (fever), MYALGIA (Extreme body ache), CHILLS (Chills,) and FATIGUE (fatigue). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 30-Mar-2021, PYREXIA (fever) had resolved. At the time of the report, SWELLING (Neck swelling), GOITRE (Swollen Neck and thyroid,), PAIN IN EXTREMITY (soreness in the opposite arm), TACHYCARDIA (Rapid HR,), MYALGIA (Extreme body ache), CHILLS (Chills,) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Body temperature: 103 (High) 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications information was not reported. Treatment information was not provided.    This case was linked to MOD21-080553 (E2B Linked Report).; Sender's Comments:  MOD21-080553:
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Swelling, Tachycardia
Clinical narrative: Neck swelling; Swollen Neck and thyroid,; soreness in the opposite arm; Rapid HR,; fever; Extreme body ache; Chills,; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Neck swelling), GOITRE (Swollen Neck and thyroid,), PAIN IN EXTREMITY (soreness in the opposite arm), TACHYCARDIA (Rapid HR,) and PYREXIA (fever) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced SWELLING (Neck swelling), GOITRE (Swollen Neck and thyroid,), PAIN IN EXTREMITY (soreness in the opposite arm), TACHYCARDIA (Rapid HR,), PYREXIA (fever), MYALGIA (Extreme body ache), CHILLS (Chills,) and FATIGUE (fatigue). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 30-Mar-2021, PYREXIA (fever) had resolved. At the time of the report, SWELLING (Neck swelling), GOITRE (Swollen Neck and thyroid,), PAIN IN EXTREMITY (soreness in the opposite arm), TACHYCARDIA (Rapid HR,), MYALGIA (Extreme body ache), CHILLS (Chills,) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Body temperature: 103 (High) 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications information was not reported. Treatment information was not provided.    This case was linked to MOD21-080553 (E2B Linked Report).; Sender's Comments:  MOD21-080553:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient did not receive  second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient did not receive  second dose) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not receive  second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient did not receive  second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information were not provided. No concomitant medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Light chain analysis increased
Clinical narrative: Light chain analysis dramatically increased; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIGHT CHAIN ANALYSIS INCREASED (Light chain analysis dramatically increased) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple myeloma (in remission).   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIGHT CHAIN ANALYSIS INCREASED (Light chain analysis dramatically increased). At the time of the report, LIGHT CHAIN ANALYSIS INCREASED (Light chain analysis dramatically increased) outcome was unknown. Not Provided          Patient's concomitant medication included unspecified multiple immunosuppressants.   Treatment information was not provided.   This case was linked to MOD-2021-085958 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hyperhidrosis
Clinical narrative: alert and sweaty; fatigued; This spontaneous case was reported by a physician and describes the occurrence of HYPERHIDROSIS (alert and sweaty) and FATIGUE (fatigued) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (alert and sweaty) and FATIGUE (fatigued). At the time of the report, HYPERHIDROSIS (alert and sweaty) and FATIGUE (fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: mild fever with first dose; Headache with first dose; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (mild fever with first dose) and HEADACHE (Headache with first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (mild fever with first dose) and HEADACHE (Headache with first dose). At the time of the report, PYREXIA (mild fever with first dose) and HEADACHE (Headache with first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-086025 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086025:
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site mass
Clinical narrative: her arm was little bit sore; there was a small bump on the injection area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm was little bit sore) and VACCINATION SITE MASS (there was a small bump on the injection area) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (her arm was little bit sore) and VACCINATION SITE MASS (there was a small bump on the injection area). At the time of the report, PAIN IN EXTREMITY (her arm was little bit sore) and VACCINATION SITE MASS (there was a small bump on the injection area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Influenza like illness
Clinical narrative: Shingles outbreak; Felt like a mild flu; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles outbreak) and INFLUENZA LIKE ILLNESS (Felt like a mild flu) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included ATORVASTATIN, DEXLANSOPRAZOLE (DEXILANT), MORPHINE SULFATE (MS CONTIN), METHOTREXATE, MONTELUKAST SODIUM (SINGULAIR), OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]), PREGABALIN (LYRICA), PREDNISONE, FOLIC ACID, RIVAROXABAN (XARELTO) and LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced HERPES ZOSTER (Shingles outbreak) and INFLUENZA LIKE ILLNESS (Felt like a mild flu). The patient was treated with ACYCLOVIR [ACICLOVIR] at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles outbreak) and INFLUENZA LIKE ILLNESS (Felt like a mild flu) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Body temperature, Myalgia, Pollakiuria
Clinical narrative: Body so weak he can't get up; Going to the bathroom every hour to urinate; Equilibrium is off; Knot at the injection site; Fever 101.0; Hurt likes hell; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Body so weak he can't get up), POLLAKIURIA (Going to the bathroom every hour to urinate), BALANCE DISORDER (Equilibrium is off), VACCINATION SITE INDURATION (Knot at the injection site) and PYREXIA (Fever 101.0) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Body so weak he can't get up), POLLAKIURIA (Going to the bathroom every hour to urinate), BALANCE DISORDER (Equilibrium is off), VACCINATION SITE INDURATION (Knot at the injection site), PYREXIA (Fever 101.0) and MYALGIA (Hurt likes hell). At the time of the report, ASTHENIA (Body so weak he can't get up), POLLAKIURIA (Going to the bathroom every hour to urinate), BALANCE DISORDER (Equilibrium is off), VACCINATION SITE INDURATION (Knot at the injection site), PYREXIA (Fever 101.0) and MYALGIA (Hurt likes hell) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) Fever 101.0.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.